Search for: "Does 1 - 35" Results 121 - 140 of 9,709
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Jan 2013, 3:58 pm
As you have no doubt heard, on January 1, 2013, Congress passed a compromise bill to avoid the 'fiscal cliff.' [read post]
26 Oct 2007, 7:02 am
“[M]ere inclusion in Title 35 of the United States Code does not make a statute a patent law under which a claim may arise. [read post]
30 Sep 2015, 3:25 am
" The combination of SMART and SERIES "does not result in a mark which as a whole has a nondescriptive or incongruous meaning. [read post]
16 Feb 2015, 4:57 pm by Lawrence B. Ebert
 An RPI that is barred under § 315(b) would bar a petitioner from institution. (35 U.S.C. [read post]
6 Jan 2011, 1:39 pm by Jeffrey A. Cramer
  If Congress does nothing, on January 1, 2013, the estate tax exemption will be reduced to $1,000,000.00 and the estate tax rate will increase to 55%. [read post]
Background Last week the Supreme Court handed down judgment in R (T) v Secretary of State for the Home Department [2014] UKSC 35. [read post]
As of January 1, 2023, Tennessee will require all private employers with at least 35 employees to use E-Verify and maintain E-Verify case results. [read post]
1 Oct 2015, 6:56 am by Docket Navigator
Time Warner Cable, Inc.; Oceanic Time Warner Cable, LLC, 1-15-cv-00131 (HID September 29, 2015, Order) (Kay, M.J.) [read post]
9 Feb 2016, 6:51 am by Docket Navigator
Cognizant Technology Solutions Corporation, 1-14-cv-01192 (DED February 5, 2016, Order) (Burke, M.J.) [read post]
6 Jul 2009, 10:01 am by Alain Leibman
In a 2-1 decision, the court of appeals held in Grant that current Rule 35(b) requires only that cooperation be the condition precedent to any reduction; it no longer requires, as did a previous iteration of the Rule, that any reduction "reflect" that cooperation. [read post]
2 Nov 2006, 8:11 am
(Source: Amgen's press release) Hoffman-LaRoche based its motion to dismiss on the assertion that all of the allegedly infringing activities fell under 35 U.S.C. 271(e)(1), which exempts activities reasonably related to the development of information necessary for FDA approval. [read post]